Skip to content

Canceled by the investigator. An observational study on the characteristics of immune response to novel coronavirus (COVID-19) inactivated vaccine inoculated in adult HIV infected persons

An observational study on the characteristics of immune response to novel coronavirus inactivated vaccine inoculated in adult HIV infected persons

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045631
Enrollment
Unknown
Registered
2021-04-20
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired immunodeficiency syndrome, AIDS

Interventions

Case series:Vaccination with Novel Coronavirus vaccine

Sponsors

The Sixth People's Hospital of Shenyang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Planned vaccination of COVID-19 vaccine; 2. Confirmation of HIV infection; 3. Participants who are willing and able to follow all scheduled follow-up, vaccination schedules, laboratory examinations, and other study procedures; 4. Voluntary vaccination with no contraindication; 5. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Under the age of 18 years; 2. Pregnant and lactating women; 3. Other conditions deemed unsuitable for inclusion in the study, such as uncontrolled severe neurological diseases, uncontrolled acute infections or acute onset of chronic diseases, etc.; 4. Currently uncured opportunistic infections and tumors: pneumocystis pneumonia, tuberculosis, toxoplasmosis, cytomegalovirus infection, other fungi, viruses, bacterial infections, lymphoma, Kapogee's sarcoma, etc.; 5. Patients with impaired immune function not caused by HIV infection.

Design outcomes

Primary

MeasureTime frame
novel coronavirus neutralize;specific antibody;

Countries

China

Contacts

Public ContactLyu Cheng

The Sixth People's Hospital of Shenyang

516184318@qq.com+86 15840223026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026